The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
 
Li Zhang
Consulting or Advisory Role - MSD
Research Funding - Lilly; MSD
 
Shun Lu
Consulting or Advisory Role - Boehringer Ingelheim; Roche
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Hutchison MediPharma
 
Ji Feng Feng
No Relationships to Disclose
 
Arunee Dechaphunkul
No Relationships to Disclose
 
Salvatore Chessari
Employment - Helsinn Healthcare
 
Corinna Lanzarotti
Employment - Helsinn Healthcare
 
Karin Jordan
Consulting or Advisory Role - Helsinn Healthcare; Merck; MSD; Tesaro
 
Matti S. Aapro
Honoraria - Amgen
Consulting or Advisory Role - Helsinn Healthcare; Hospira; Merck; Merck KGaA; Pierre Fabre; Sandoz; Tesaro; Teva; Vifor Pharma
Speakers' Bureau - Amgen; Helsinn Healthcare; Hospira; Johnson & Johnson; Novartis; Pierre Fabre; Roche; Sandoz; Tesaro; Teva; Vifor Pharma
Research Funding - Helsinn Healthcare (Inst); Hospira; Novartis (Inst); Pierre Fabre (Inst); Sandoz
Expert Testimony - Amgen